{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:47:56Z","timestamp":1790416076946,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-014-2021-4","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T09:02:11Z","timestamp":1393491731000},"source":"Crossref","is-referenced-by-count":12,"title":["Histone deacetylase inhibitor prevents cell growth in Burkitt\u2019s lymphoma by regulating PI3K\/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101"],"prefix":"10.1007","author":[{"given":"Ana Carolina","family":"dos Santos Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Cristina","family":"Robaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia Maria Magalh\u00e3es","family":"de Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudete Esteves","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"issue":"6","key":"2021_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11912-007-0064-6","volume":"9","author":"TG Gross","year":"2007","unstructured":"Gross TG, Termuhlen AM (2007) Pediatric non-Hodgkin\u2019s lymphoma. Curr Oncol Rep 9(6):459\u2013465","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2021_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) MYC on the path to cancer. Cell 149(1):22\u201335. doi: 10.1016\/j.cell.2012.03.003","journal-title":"Cell"},{"issue":"4","key":"2021_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","volume":"149","author":"K Klapproth","year":"2010","unstructured":"Klapproth K, Wirth T (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 149(4):484\u2013497. doi: 10.1111\/j.1365-2141.2010.08159.x","journal-title":"Br J Haematol"},{"issue":"4","key":"2021_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2006.07.011","volume":"16","author":"N Meyer","year":"2006","unstructured":"Meyer N, Kim SS, Penn LZ (2006) The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 16(4):275\u2013287. doi: 10.1016\/j.semcancer.2006.07.011","journal-title":"Semin Cancer Biol"},{"issue":"21","key":"2021_CR5","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht JL, Aster JC (2000) Molecular biology of Burkitt\u2019s lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 18(21):3707\u20133721","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"2021_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-0609.2003.00094.x","volume":"71","author":"CE Klumb","year":"2003","unstructured":"Klumb CE, Furtado DR, de Resende LM, Carrico MK, Coelho AM, de Meis E, Maia RC, Rumjanek FD (2003) DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin\u2019s lymphomas: prognostic implications. Eur J Haematol 71(2):81\u201390","journal-title":"Eur J Haematol"},{"issue":"15","key":"2021_CR7","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1093\/nar\/gks391","volume":"40","author":"K Paschos","year":"2012","unstructured":"Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ (2012) BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res 40(15):7233\u20137246. doi: 10.1093\/nar\/gks391","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2021_CR8","doi-asserted-by":"crossref","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K Paschos","year":"2009","unstructured":"Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ (2009) Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog 5(6):e1000492. doi: 10.1371\/journal.ppat.1000492","journal-title":"PLoS Pathog"},{"issue":"2","key":"2021_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","volume":"22","author":"S Sander","year":"2012","unstructured":"Sander S, Calado DP, Srinivasan L, Kochert K, Zhang B, Rosolowski M, Rodig SJ, Holzmann K, Stilgenbauer S, Siebert R, Bullinger L, Rajewsky K (2012) Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22(2):167\u2013179. doi: 10.1016\/j.ccr.2012.06.012","journal-title":"Cancer Cell"},{"issue":"7418","key":"2021_CR10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120. doi: 10.1038\/nature11378","journal-title":"Nature"},{"issue":"1","key":"2021_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/138161210789941865","volume":"16","author":"A Carnero","year":"2010","unstructured":"Carnero A (2010) The PKB\/AKT pathway in cancer. Curr Pharm Des 16(1):34\u201344","journal-title":"Curr Pharm Des"},{"issue":"10","key":"2021_CR12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s10495-012-0742-1","volume":"17","author":"A Rasul","year":"2012","unstructured":"Rasul A, Ding C, Li X, Khan M, Yi F, Ali M, Ma T (2012) Dracorhodin perchlorate inhibits PI3K\/Akt and NF-kappaB activation, up-regulates the expression of p53, and enhances apoptosis. Apoptosis: Int J Programmed Cell Death 17(10):1104\u20131119. doi: 10.1007\/s10495-012-0742-1","journal-title":"Apoptosis: Int J Programmed Cell Death"},{"issue":"1","key":"2021_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2011.10.016","volume":"315","author":"KB Lee","year":"2012","unstructured":"Lee KB, Byun HJ, Park SH, Park CY, Lee SH, Rho SB (2012) CYR61 controls p53 and NF-kappaB expression through PI3K\/Akt\/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett 315(1):86\u201395. doi: 10.1016\/j.canlet.2011.10.016","journal-title":"Cancer Lett"},{"issue":"5","key":"2021_CR14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V91.5.1680","volume":"91","author":"U Klangby","year":"1998","unstructured":"Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG (1998) p16\/INK4a and p15\/INK4b gene methylation and absence of p16\/INK4a mRNA and protein expression in Burkitt\u2019s lymphoma. Blood 91(5):1680\u20131687","journal-title":"Blood"},{"issue":"1","key":"2021_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12046","volume":"253","author":"VG Yebenes de","year":"2013","unstructured":"de Yebenes VG, Bartolome-Izquierdo N, Ramiro AR (2013) Regulation of B-cell development and function by microRNAs. Immunol Rev 253(1):25\u201339. doi: 10.1111\/imr.12046","journal-title":"Immunol Rev"},{"issue":"6","key":"2021_CR16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590\u2013610. doi: 10.1016\/j.molonc.2012.09.006","journal-title":"Mol Oncol"},{"issue":"2","key":"2021_CR17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00432-011-1093-y","volume":"138","author":"AC Santos Ferreira Dos","year":"2012","unstructured":"Dos Santos Ferreira AC, Fernandes RA, Kwee JK, Klumb CE (2012) Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt\u2019s lymphoma cells. J Cancer Res Clin Oncol 138(2):317\u2013325. doi: 10.1007\/s00432-011-1093-y","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2021_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2011\/157829","volume":"30","author":"N Vasiljevic","year":"2011","unstructured":"Vasiljevic N, Wu K, Brentnall AR, Kim DC, Thorat MA, Kudahetti SC, Mao X, Xue L, Yu Y, Shaw GL, Beltran L, Lu YJ, Berney DM, Cuzick J, Lorincz AT (2011) Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers 30(4):151\u2013161. doi: 10.3233\/DMA-2011-0790","journal-title":"Dis Markers"},{"issue":"12","key":"2021_CR19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nrc1753","volume":"5","author":"AG Bader","year":"2005","unstructured":"Bader AG, Kang S, Zhao L, Vogt PK (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5(12):921\u2013929. doi: 10.1038\/nrc1753","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2021_CR20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.bcp.2006.12.032","volume":"73","author":"JN Ou","year":"2007","unstructured":"Ou JN, Torrisani J, Unterberger A, Provencal N, Shikimi K, Karimi M, Ekstrom TJ, Szyf M (2007) Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 73(9):1297\u20131307. doi: 10.1016\/j.bcp.2006.12.032","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2021_CR21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/annonc\/mdn031","volume":"19","author":"M Crump","year":"2008","unstructured":"Crump M, Coiffier B, Jacobsen ED, Sun L, Ricker JL, Xie H, Frankel SR, Randolph SS, Cheson BD (2008) Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma. Ann Oncol: Off J Eur Soc Med Oncol\/ESMO 19(5):964\u2013969. doi: 10.1093\/annonc\/mdn031","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ESMO"},{"key":"2021_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","volume":"3","author":"J Tan","year":"2010","unstructured":"Tan J, Cang S, Ma Y, Petrillo RL, Liu D (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 3:5. doi: 10.1186\/1756-8722-3-5","journal-title":"J Hematol Oncol"},{"key":"2021_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-8722-2-31","volume":"2","author":"D Siegel","year":"2009","unstructured":"Siegel D, Hussein M, Belani C, Robert F, Galanis E, Richon VM, Garcia-Vargas J, Sanz-Rodriguez C, Rizvi S (2009) Vorinostat in solid and hematologic malignancies. J Hematol Oncol 2:31. doi: 10.1186\/1756-8722-2-31","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2021_CR24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2141.2001.02647.x","volume":"112","author":"A Atra","year":"2001","unstructured":"Atra A, Gerrard M, Hobson R, Imeson JD, Hann IM, Pinkerton CR (2001) Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin\u2019s lymphoma treated with the UKCCSG 9003\/9002 protocols. Br J Haematol 112(4):965\u2013968","journal-title":"Br J Haematol"},{"issue":"4","key":"2021_CR25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","volume":"120","author":"MS Cairo","year":"2003","unstructured":"Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL (2003) Burkitt\u2019s and Burkitt-like lymphoma in children and adolescents: a review of the Children\u2019s Cancer Group experience. Br J Haematol 120(4):660\u2013670","journal-title":"Br J Haematol"},{"issue":"2","key":"2021_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.21753","volume":"52","author":"TC Griffin","year":"2009","unstructured":"Griffin TC, Weitzman S, Weinstein H, Chang M, Cairo M, Hutchison R, Shiramizu B, Wiley J, Woods D, Barnich M, Gross TG (2009) A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent\/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 52(2):177\u2013181. doi: 10.1002\/pbc.21753","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2021_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molonc.2008.03.005","volume":"2","author":"MP Lambert","year":"2008","unstructured":"Lambert MP, Herceg Z (2008) Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007. Mol Oncol 2(1):33\u201340. doi: 10.1016\/j.molonc.2008.03.005","journal-title":"Mol Oncol"},{"issue":"9","key":"2021_CR28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/ijc.25218","volume":"127","author":"W Shao","year":"2010","unstructured":"Shao W, Growney JD, Feng Y, O\u2019Connor G, Pu M, Zhu W, Yao YM, Kwon P, Fawell S, Atadja P (2010) Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: defining molecular mechanisms of resistance. Int J Cancer J Int Du Cancer 127(9):2199\u20132208. doi: 10.1002\/ijc.25218","journal-title":"Int J Cancer J Int Du Cancer"},{"issue":"10","key":"2021_CR29","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood-2006-03-009142","volume":"108","author":"G Garcia-Manero","year":"2006","unstructured":"Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Wierda WG, Ravandi F, Koller C, Xiao L, Faderl S, Estrov Z, Cortes J, O\u2019Brien S, Estey E, Bueso-Ramos C, Fiorentino J, Jabbour E, Issa JP (2006) Phase 1\/2 study of the combination of 5-aza-2\u2019-deoxycytidine with valproic acid in patients with leukemia. Blood 108(10):3271\u20133279. doi: 10.1182\/blood-2006-03-009142","journal-title":"Blood"},{"issue":"2","key":"2021_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccr.2012.07.018","volume":"22","author":"D Dominguez-Sola","year":"2012","unstructured":"Dominguez-Sola D, Dalla-Favera R (2012) Burkitt lymphoma: much more than MYC. Cancer Cell 22(2):141\u2013142. doi: 10.1016\/j.ccr.2012.07.018","journal-title":"Cancer Cell"},{"issue":"5573","key":"2021_CR31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655\u20131657. doi: 10.1126\/science.296.5573.1655","journal-title":"Science"},{"issue":"7","key":"2021_CR32","first-page":"2791","volume":"32","author":"E Jasek","year":"2012","unstructured":"Jasek E, Lis GJ, Jasinska M, Jurkowska H, Litwin JA (2012) Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. Anticancer Res 32(7):2791\u20132799","journal-title":"Anticancer Res"},{"issue":"5","key":"2021_CR33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/path.4164","volume":"229","author":"H Guan","year":"2013","unstructured":"Guan H, Xie L, Klapproth K, Weitzer CD, Wirth T, Ushmorov A (2013) Decitabine represses translocated MYC oncogene in Burkitt lymphoma. J Pathol 229(5):775\u2013783. doi: 10.1002\/path.4164","journal-title":"J Pathol"},{"issue":"3","key":"2021_CR34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","volume":"28","author":"S Milutinovic","year":"2007","unstructured":"Milutinovic S, D\u2019Alessio AC, Detich N, Szyf M (2007) Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28(3):560\u2013571. doi: 10.1093\/carcin\/bgl167","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"2021_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1006831330340","volume":"188","author":"B Schwartz","year":"1998","unstructured":"Schwartz B, Avivi-Green C, Polak-Charcon S (1998) Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 188(1\u20132):21\u201330","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2021_CR36","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2002-07-2009","volume":"101","author":"M Sanchez-Beato","year":"2003","unstructured":"Sanchez-Beato M, Sanchez-Aguilera A, Piris MA (2003) Cell cycle deregulation in B-cell lymphomas. Blood 101(4):1220\u20131235. doi: 10.1182\/blood-2002-07-2009","journal-title":"Blood"},{"key":"2021_CR37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1476-4598-9-136","volume":"9","author":"A Iio","year":"2010","unstructured":"Iio A, Nakagawa Y, Hirata I, Naoe T, Akao Y (2010) Identification of non-coding RNAs embracing microRNA-143\/145 cluster. Mol Cancer 9:136. doi: 10.1186\/1476-4598-9-136","journal-title":"Mol Cancer"},{"issue":"2","key":"2021_CR38","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/bcj.2012.1","volume":"2","author":"L Lisio Di","year":"2012","unstructured":"Di Lisio L, Sanchez-Beato M, Gomez-Lopez G, Rodriguez ME, Montes-Moreno S, Mollejo M, Menarguez J, Martinez MA, Alves FJ, Pisano DG, Piris MA, Martinez N (2012) MicroRNA signatures in B-cell lymphomas. Blood Cancer J 2(2):e57. doi: 10.1038\/bcj.2012.1","journal-title":"Blood Cancer J"},{"issue":"6","key":"2021_CR39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/cgt.2009.88","volume":"17","author":"Y Akao","year":"2010","unstructured":"Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y, Naoe T (2010) Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 17(6):398\u2013408. doi: 10.1038\/cgt.2009.88","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"2021_CR40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","volume":"98","author":"Y Akao","year":"2007","unstructured":"Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T (2007) Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 98(12):1914\u20131920. doi: 10.1111\/j.1349-7006.2007.00618.x","journal-title":"Cancer Sci"},{"issue":"9","key":"2021_CR41","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","volume":"106","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 106(9):3207\u20133212. doi: 10.1073\/pnas.0808042106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2021_CR42","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1111\/febs.12013","volume":"279","author":"XP He","year":"2012","unstructured":"He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, Xu HC, Xu X, Tang D, Zheng XF, Xue YP, Huang GC, Sun WH (2012) Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J 279(22):4201\u20134212. doi: 10.1111\/febs.12013","journal-title":"FEBS J"},{"issue":"12","key":"2021_CR43","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ejca.2010.05.012","volume":"46","author":"HJ Wang","year":"2010","unstructured":"Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46(12):2295\u20132303. doi: 10.1016\/j.ejca.2010.05.012","journal-title":"Eur J Cancer"},{"issue":"8","key":"2021_CR44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.18632\/oncotarget.205","volume":"1","author":"M Smits","year":"2010","unstructured":"Smits M, Nilsson J, Mir SE, van der Stoop PM, Hulleman E, Niers JM, de Witt Hamer PC, Marquez VE, Cloos J, Krichevsky AM, Noske DP, Tannous BA, Wurdinger T (2010) miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 1(8):710\u2013720","journal-title":"Oncotarget"},{"issue":"5","key":"2021_CR45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3892\/etm.2011.284","volume":"2","author":"HM Cho","year":"2011","unstructured":"Cho HM, Jeon HS, Lee SY, Jeong KJ, Park SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, Na MJ, Kang J, Son JW (2011) microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med 2(5):963\u2013967. doi: 10.3892\/etm.2011.284","journal-title":"Exp Ther Med"},{"issue":"1","key":"2021_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40(1):43\u201350. doi: 10.1038\/ng.2007.30","journal-title":"Nat Genet"},{"issue":"6","key":"2021_CR47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y, Kok K, Rosati S, Schuuring E, van Imhoff G, Pals ST, Kluin P, van den Berg A (2010) MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 149(6):896\u2013899. doi: 10.1111\/j.1365-2141.2010.08111.x","journal-title":"Br J Haematol"},{"issue":"4","key":"2021_CR48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","volume":"31","author":"CS Chim","year":"2010","unstructured":"Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, Jin DY, Costello JF, Liang R (2010) Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 31(4):745\u2013750. doi: 10.1093\/carcin\/bgq033","journal-title":"Carcinogenesis"},{"issue":"6","key":"2021_CR49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","volume":"13","author":"MJ Bueno","year":"2008","unstructured":"Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernandez-Piqueras J, Malumbres M (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13(6):496\u2013506. doi: 10.1016\/j.ccr.2008.04.018","journal-title":"Cancer Cell"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2021-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T20:46:44Z","timestamp":1597524404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":49,"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2021-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}